Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Up – Here’s What Happened

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) gapped up prior to trading on Monday . The stock had previously closed at $9.19, but opened at $9.73. Nihon Kohden shares last traded at $9.73, with a volume of 446 shares trading hands.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Nihon Kohden Stock Performance

The stock has a market cap of $1.63 billion, a price-to-earnings ratio of 16.44 and a beta of 0.39. The company has a 50-day simple moving average of $9.03 and a two-hundred day simple moving average of $9.87.

Nihon Kohden (OTCMKTS:NHNKY) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. The company had revenue of $453.10 million for the quarter, compared to analysts’ expectations of $414.40 million. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%. As a group, sell-side analysts predict that Nihon Kohden Corporation will post 0.6 earnings per share for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.